Medlab Clinical Ltd
ASX:MDC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Henan Thinker Automatic Equipment Co Ltd
SSE:603508
|
CN |
|
Securitas AB
STO:SECU B
|
SE |
|
H
|
Harbin Sayyas Windows Co Ltd
SZSE:301227
|
CN |
|
Companhia de Saneamento de Minas Gerais Copasa MG
BOVESPA:CSMG3
|
BR |
|
Shenzhen Jame Technology Corp Ltd
SZSE:300868
|
CN |
Medlab Clinical Ltd
Operating Expenses
Medlab Clinical Ltd
Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medlab Clinical Ltd
ASX:MDC
|
Operating Expenses
-AU$2.3m
|
CAGR 3-Years
42%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
Mesoblast Ltd
ASX:MSB
|
Operating Expenses
-$111.3m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-4%
|
|
|
CSL Ltd
ASX:CSL
|
Operating Expenses
-$4B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-11%
|
|
|
Race Oncology Ltd
ASX:RAC
|
Operating Expenses
-AU$11.6m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Operating Expenses
-AU$350.9m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-55%
|
CAGR 10-Years
N/A
|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Operating Expenses
-AU$71m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
-30%
|
|
Medlab Clinical Ltd
Glance View
Medlab Clinical Ltd. engages in the development of therapeutic pathways for diagnosed chronic diseases. The company is headquartered in Alexandria, New South Wales. The company went IPO on 2015-07-14. Medlab’s pipeline comprises a number of small and large molecules from repurposing generic medicines to enhancing the delivery of immunotherapies. The firm's lead drug candidate, NanaBis, is under development for cancer bone pain as an alternative to opioid use. The firm also has a drug delivery platform called NanoCelle, which is wholly owned by Medlab and developed in Medlab’s owned Office of the Gene Technology Regulator (OGTR) registered laboratory. NanoCelle is designed to address known medication problems, addressing global unmet medical needs. Medlab operates in Australia, United States, and the United Kingdom.
See Also
What is Medlab Clinical Ltd's Operating Expenses?
Operating Expenses
-2.3m
AUD
Based on the financial report for Jun 30, 2024, Medlab Clinical Ltd's Operating Expenses amounts to -2.3m AUD.
What is Medlab Clinical Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
29%
Over the last year, the Operating Expenses growth was 72%. The average annual Operating Expenses growth rates for Medlab Clinical Ltd have been 42% over the past three years , 29% over the past five years .
